Lexington, KY – July 15, 2015

Omega Ophthalmics LLC (Omega) is pleased to announce that the company has successfully raised a Series A investment from private investors. This first round of financing is intended to carry Omega through its animal trials and begin the “first in man” clinical trials for its medical device as required by FDA regulations.

Clinical animal studies has shown this capsular bag to be remarkably effective in helping maintain effective lens position as compared to other intraocular lenses, a critical component of cataracts surgery that determines whether or not a patient will need post-operative corrective lenses. The first human trials are scheduled to begin at the end of this year.

Read more